semaglutide legal Novo Nordisk to protect US patients from unlawful sales of non-FDA approved 'semaglutide medicines' Ozempic | Simon Law

See if You Qualify The Wegovy Blood Clot Lawsuit is an active lawsuit See If You Qualify Nationwide, individuals are filing lawsuits against Novo Nordisk, the manufacturer of Wegovy, alleging the pharmaceutical company failed to warn patients and healthcare providers about the risk of blood clot-related injuries and health complications associated with the drugs use

All claims distinguish FDA-approved (none) from investigational/off-label findings

This warning originates from rodent studies where semaglutide caused dose-dependent thyroid C-cell tumors in rats and mice

Thank you VITAstir for being with me on my weight loss journey and maintenance

Diabetes Obes Metab 2022;24:684692 [DOI] [PubMed] [Google Scholar] 53

Semaglutide improves insulin resistance, insulin signalling pathway, and reduce body weight which are responsible for prevention or progression of NASH and neurodegenerative diseases